Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
59.32
-1.36 (-2.24%)
At close: Jan 21, 2026, 4:00 PM EST
61.30
+1.98 (3.34%)
Pre-market: Jan 22, 2026, 9:22 AM EST
Novo Nordisk (NVO) Revenue by Segment
History
| Date | Diabetes | Obesity | Rare Disease |
|---|---|---|---|
| Sep 30, 2025 | 33.65B | 12.77B | 3.13B |
| Jun 30, 2025 | 33.46B | 12.40B | 3.11B |
| Mar 31, 2025 | 33.25B | 11.39B | 2.96B |
| Dec 31, 2024 | 32.44B | 10.23B | 2.93B |
| Sep 30, 2024 | 31.11B | 8.63B | 2.75B |
| Jun 30, 2024 | 30.26B | 7.60B | 2.64B |
| Mar 31, 2024 | 28.65B | 7.04B | 2.66B |
| Dec 31, 2023 | 27.24B | 6.54B | 2.69B |
| Sep 30, 2023 | 25.30B | 5.64B | 2.74B |
| Jun 30, 2023 | 24.29B | 4.39B | 2.93B |
| Mar 31, 2023 | 23.12B | 3.35B | 3.10B |
| Dec 31, 2022 | 21.91B | 2.65B | 3.23B |
| Sep 30, 2022 | 20.88B | 2.17B | 3.20B |
| Jun 30, 2022 | 19.71B | 1.87B | 3.11B |
| Mar 31, 2022 | 18.71B | 1.61B | 3.08B |
| Dec 31, 2021 | 17.77B | 1.32B | 3.02B |
| Sep 30, 2021 | 16.59B | 1.12B | 2.98B |
| Jun 30, 2021 | 15.81B | 976.01M | 3.02B |
| Mar 31, 2021 | 15.49B | 889.65M | 2.99B |
| Dec 31, 2020 | 15.26B | 891.69M | 3.01B |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.